Growth Metrics

Lemaitre Vascular (LMAT) Asset Writedowns and Impairment (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Asset Writedowns and Impairment for 16 consecutive years, with $362000.0 as the latest value for Q4 2025.

  • Quarterly Asset Writedowns and Impairment fell 62.99% to $362000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $817000.0 through Dec 2025, down 73.58% year-over-year, with the annual reading at $817000.0 for FY2025, 73.58% down from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was $362000.0 at Lemaitre Vascular, up from -$575000.0 in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $3.6 million in Q4 2021, with the low at -$2.0 million in Q3 2021.
  • Average Asset Writedowns and Impairment over 5 years is $530200.0, with a median of $445500.0 recorded in 2022.
  • The sharpest move saw Asset Writedowns and Impairment tumbled 326.74% in 2021, then soared 5271.43% in 2024.
  • Over 5 years, Asset Writedowns and Impairment stood at $3.6 million in 2021, then crashed by 35.27% to $2.4 million in 2022, then tumbled by 147.12% to -$1.1 million in 2023, then surged by 188.03% to $978000.0 in 2024, then tumbled by 62.99% to $362000.0 in 2025.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods came in at $362000.0, -$575000.0, and $393000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.